rs886039047
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000138.5(FBN1):c.6773G>A(p.Cys2258Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C2258G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.6773G>A | p.Cys2258Tyr | missense_variant | 56/66 | ENST00000316623.10 | |
FBN1 | NM_001406716.1 | c.6773G>A | p.Cys2258Tyr | missense_variant | 55/65 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.6773G>A | p.Cys2258Tyr | missense_variant | 56/66 | 1 | NM_000138.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2015 | The p.C2258Y variant (also known as c.6773G>A), located in coding exon 55 of the FBN1 gene, results from a G to A substitution at nucleotide position 6773. The cysteine at codon 2258 is replaced by tyrosine, an amino acid with highly dissimilar properties, and is located in the cb EGF-like domain #35. The majority of FBN1 mutations identified to date have involved the substitution or generation of cysteine residues within cbEGF domains (Vollbrandt T et al. J Biol Chem. 2004;279(31):32924-32931). This variant, which was described in a patient with classic Marfan syndrome (MFS), was studied using pulse-chase analysis that demonstrated a delay in secretion of profibrillin-1, which may disrupt the folding of the protein and its transport (Halliday D et al. Hum Genet, 1999 Dec;105:587-97). Based on internal structural assessment, this alteration eliminates a structurally critical disulfide bond in the structurally sensitive cb EGF-like domain #35. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
FBN1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 07, 2024 | The FBN1 c.6773G>A variant is predicted to result in the amino acid substitution p.Cys2258Tyr. This variant was reported in an individual with Marfan syndrome (Halliday et al. 1999. PubMed ID: 10647894). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at